論文

国際誌
2021年12月20日

ENTREP/FAM189A2 encodes a new ITCH ubiquitin ligase activator that is downregulated in breast cancer.

EMBO reports
  • Takumi Tsunoda
  • Miho Riku
  • Norika Yamada
  • Hikaru Tsuchiya
  • Takuya Tomita
  • Minako Suzuki
  • Mari Kizuki
  • Akihito Inoko
  • Hideaki Ito
  • Kenta Murotani
  • Hideki Murakami
  • Yasushi Saeki
  • Kenji Kasai
  • 全て表示

23
2
開始ページ
e51182
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.15252/embr.202051182

The HECT-type ubiquitin E3 ligases including ITCH regulate many aspects of cellular function through ubiquitinating various substrates. These ligases are known to be allosterically autoinhibited and to require an activator protein to fully achieve the ubiquitination of their substrates. Here we demonstrate that FAM189A2, a downregulated gene in breast cancer, encodes a new type of ITCH activator. FAM189A2 is a transmembrane protein harboring PPxY motifs, and the motifs mediate its association with and ubiquitination by ITCH. FAM189A2 also associates with Epsin and accumulates in early and late endosomes along with ITCH. Intriguingly, FAM189A2 facilitates the association of a chemokine receptor CXCR4 with ITCH and enhances ITCH-mediated ubiquitination of CXCR4. FAM189A2-knockout prohibits CXCL12-induced endocytosis of CXCR4, thereby enhancing the effects of CXCL12 on the chemotaxis and mammosphere formation of breast cancer cells. In comparison to other activators or adaptors known in the previous studies, FAM189A2 is a unique activator for ITCH to desensitize CXCR4 activity, and we here propose that FAM189A2 be renamed as ENdosomal TRansmembrane binding with EPsin (ENTREP).

リンク情報
DOI
https://doi.org/10.15252/embr.202051182
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34927784
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811627
ID情報
  • DOI : 10.15252/embr.202051182
  • PubMed ID : 34927784
  • PubMed Central 記事ID : PMC8811627

エクスポート
BibTeX RIS